OXSQG Q1 2026 Earnings EPS Misses Estimates as Notes Decline AGBK Q1 2026 Earnings EPS Surpasses Estimates by Over 6 FGBI Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Decline JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline FULT Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations